Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • Contact Us
Pipeline News and Updates
Picture

Update for December 1, 2021

12/1/2021

 
Regulatory Update
 
The FDA approved maribavir (Livtencity, Takeda), on 11/23/2021, to treat resistant, post-transplant, cytomegalovirus (CMV) infection/disease.
 
The FDA approved pafolacianine (Cytalux, On Target Laboratories), on 11/29/2021, as an adjunct fluorescent imaging agent for intraoperative identification of malignant ovarian cancer lesions.
 
The FDA extended the PDUFA date for Oleogel-S10 to allow additional time to review new data. The new PDUFA date is 2/28/2022
 
Zenas BioPharma acquired worldwide rights to develop and market obexelimab.
 
Announced Research Updates
 
Gilead and Merck announced they are temporarily pausing a 48-week, 75 patient, Phase II trial evaluating the once-weekly combination of islatravir and lenacapavir in maintenance of virologically suppressed HIV as Merck investigates the decrease in immune response in a trial evaluating MK-8507 and islatravir.
 
Santhera and ReveraGen announced 48-week results from 114 patients that continued treatment in the VISION-DMD trial, where continued treatment with vamorolone or a change from prednisone to vamorolone maintained TTSTAND.
 
Pfizer announced that in the 24-week, 286 patient, Phase IIB TRANSLATE-TIMI 70 trial, treatment with vupanorsenreduced non-HDL-C compared to placebo in patients with elevated non-HDL-C and triglycerides who were receiving a stable statin dose.

Comments are closed.
    Stay informed, subscribe to the 
    ​
    Prescribe Right Pharmaceutical Pipeline Tracker
    Latest Tweets from Prescribe Right

    Archives

    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    August 2015

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.